9 out of 10 dentists say they want a less-painful, faster-acting anesthetic.3 We invented one. Our patented solution could be worth $22 million in revenue for every 1% of market share we get.6 Now we need your help to finish FDA trials and start taking the pain out of visiting the dentist.
The numbing shots dentists use are filled with an acidic preservative. That acid causes the shot to sting as it's injected. Nearly 60% of dental patients say the numbing shot is the worst part of going to the dentist. And what dentist wants to cause a patient pain? No wonder 9 out of 10 dentists want to give a less painful shot too.
Acid, added to preserve local anesthetics, is irritating to gum tissue and must be slowly neutralized by the body to activate the drug. This causes pain and delays nerve blockade onset.
Our patented Libracaine cartridge gives dentists a buffered anesthetic that fits inside a standard dental syringe for the first time in medical history. The novel design combines a bicarbonate buffering agent with the acidic anesthetic as the syringe is pressed, neutralizing the pain-causing acid as it’s injected.
Balanced Pharma is pioneering the movement toward faster-acting, less painful dental injections.
Become an investor today!
Simple and consistent buffering in a standard dental cartridge will be a game-changer.
Our novel anesthetic cartridge received patent protection in April 2022. Currently, we’re making our way through the FDA approval process and are looking for investors to help us cross the finish line. You have the unique opportunity to help get this solution out of the lab and into dentists’ hands by investing today.
Balanced Pharma is pioneering the movement toward faster-acting, less painful dental injections.
Become an investor today!
After 30 years as a practicing dentist, Dr. Scott Keadle knew anesthetics needed improvement:
Patented technology that neutralizes the acid in dental anesthetics:
Dedicated to solving the problem, Dr. Keadle invented a dual-chambered dental cartridge that provides an acid-free (“buffered”) version of the most common dental anesthetics, using a standard syringe and protocol.
Teaming up with dentists to bring a long-sought anesthetic to market:
Dr. Keadle presented his technology to dental colleagues who invested over $1 million to help found Balanced Pharma, Incorporated (BPI). Now a team of industry experts are building upon the patented technology he created to bring the first-ever acid-free (“buffered”) dental anesthetic to market.
Join the Balanced Pharma mailing list to receive live investor updates!
